Our data suggest that circulating OPN in plasma may reflect early changes in NAFLD in the absence of fibrosis and before inflammation as assessed by standard histology becomes overt and underscores its potential utility as a noninvasive marker in NAFLD, as suggested by others [20, 22]. Here, SPP1 is linked to metabolic dysfunction-associated steatotic liver disease.